Casting a wide net for anemia in advanced prostate cancer: A case series

Anemia is a common occurrence in patients with prostate cancer and has numerous associated etiologies including androgen deprivation, radiation toxicity, bone marrow infiltration from cancer, anemia of chronic inflammation, poor nutritional status and bone marrow suppression from chemotherapy. Anemi...

Full description

Saved in:
Bibliographic Details
Published in:Current problems in cancer. Case reports Vol. 19; p. 100389
Main Authors: Zafar, Aneeqa, Veeravelli, Sumana, Iczkowski, Kenneth, Graff, John Paul, Kaesberg, Paul, Parikh, Mamta
Format: Journal Article
Language:English
Published: Elsevier Inc 01.09.2025
Elsevier
Subjects:
Androgen deprivation therapy
Anemia
Hematology, Oncology, and Palliative Medicine
Hemolytic anemia
Prostate cancer
Androgen deprivation therapy
Hemolytic anemia
Anemia
Prostate cancer
ISSN:2666-6219, 2666-6219
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anemia is a common occurrence in patients with prostate cancer and has numerous associated etiologies including androgen deprivation, radiation toxicity, bone marrow infiltration from cancer, anemia of chronic inflammation, poor nutritional status and bone marrow suppression from chemotherapy. Anemia in metastatic castration resistant prostate cancer (mCRPC) has been associated with a worse prognosis. While anemia associated with solid tumors generally is attributable to either the malignancy or the treatment given for the malignancy, prostate cancer is unique in that it is an indolent disease with fewer cytotoxic treatments and primarily affecting a geriatric population, thus leading to more varied causes of anemia. Non-treatment related causes of anemia ought to be recognized to prevent further morbidity and mortality in this vulnerable patient population. We outline cases that exemplify this spectrum.
ISSN:2666-6219
2666-6219
DOI:10.1016/j.cpccr.2025.100389